Evidence map›Paper›PMID 42737765›Full record

ArticleInternational journal of molecular sciences2026

METTL14-Mediated lncRNA MSTRG.292666.16 m

Qinfang Deng, Hui Sun, Heyong Wang, Chenlei Cai, Xianxiu Ji, Qiyu Fang, Boxiong Xie, Songwen Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qinfang DengDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Hui SunDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Heyong WangCentral Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Chenlei CaiDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Xianxiu JiDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Qiyu FangDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Boxiong XieDepartment of Thoracic, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
Songwen ZhouDepartment of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.

Funding

Shanghai Pulmonary Hospital National Fund Cultivation Project No. fkzr2568
6 · The paper itself

Abstract

Non-small-cell lung cancer (NSCLC) treatment is hampered by its complex pathogenesis and high heterogeneity. N6-methyladenosine (m

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMAP Kinase Signaling SystemMethyltransferasesRNA, Long NoncodingA549 CellsAdenosineAnimalsApoptosisCell Line, TumorCell MovementCell ProliferationDisease ProgressionEpitranscriptomeFemaleGene Expression Regulation, NeoplasticAdenosineMethyltransferasesMETTL14 protein, humanN-methyladenosineRNA, Long NoncodinglncRNA MSTRG.292666.16m6A modificationMAPK pathwayMETTL14non-small-cell lung cancer

Identifiers

PMID42737765
PMCPMC13566235

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.